Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Arthritis, Rheumatoid × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 169 Breast Neoplasms 99 Neoplasms 70 Prostatic Neoplasms 25 Fatigue 24 Colorectal Neoplasms 18 Obesity 17 Lung Neoplasms 13 Polycystic Ovary Syndrome 11 Ovarian Neoplasms 10 Lymphedema 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Multiple Myeloma 8 Hematologic Neoplasms 8 Head and Neck Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Pancreatic Neoplasms 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Insulin Resistance 6 Brain Neoplasms 6 Weight Loss 5 Sarcopenia 5 Esophageal Neoplasms 5 Endometrial Neoplasms 5 Breast Cancer Lymphedema 5 Stomach Neoplasms 4

Interventions

Vitamin D 1 Syringes 1 Lysine Acetyltransferase 5 1 Holistic Health 1 High-Intensity Interval Training 1 Fish Oils 1 Fatty Acids, Omega-3 1 Exercise 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Calcitriol 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05215509 2024-02-02

RABEX

Rigshospitalet, Denmark

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡